Scarica l'app Stockscreener
26.82
7.10%
-2.05
Dopo l'orario di chiusura:
26.90
0.08
+0.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Fell 7% and Wall Street’s Price Target Now Sits Below the Stock - TIKR.com
A Look at Hims & Hers Health Inc (HIMS) After 7.1% Decline -- GF Value $38.10 vs Price $26.82 - GuruFocus
Hims & Hers at The Economist's Inaugural Economics of Obesity and Metabolic Health Summit - Hims & Hers Newsroom
Hims & Hers Health Stock Slides Friday: What's Going On? - Benzinga
Hims & Hers Health, Inc. (HIMS) stock drops despite market gains: Important facts to note - MSN
HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic's AI Leap As Lilly, WeightWatchers Turn Up The Heat - Stocktwits
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance
Hims & Hers Health (HIMS) up 15.8% since last earnings report: Can it continue? - MSN
OMCL vs. HIMS: Which Stock Is the Better Value Option? - Yahoo Finance
Hims & Hers Health (HIMS) Up 15.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Downgraded to "Strong Sell" Rating by Zacks Research - MarketBeat
Investor relations - HIMS Investor Relations
Hims & Hers (HIMS) Stock: Investors Reassess Growth Path in Digital Health Weight-Loss Push - parameter.io
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz - The National Law Review
Why Hims & Hers Stock Jumped Today as Its Weight-Loss Bet Gets a Second Look - TechStock²
Hims & Hers Health Jumps 5.0% Amid Sector-Wide Rally - AlphaStreet
Hims & Hers Stock Edges Higher: What's Going On? - Benzinga
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating - Moomoo
X Square Capital LLC Raises Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.7% Rally? GF Value Says Undervalued - GuruFocus
Is It Too Late to Buy Hims & Hers Health Inc (HIMS) After 3.7% R - GuruFocus
HIMS Stock Slips Despite Early Eucalyptus Buyout Close: Analyst Sees 10% Downside On GLP-1 Profit Risks - Stocktwits
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
Investors heavily search Hims & Hers Health, Inc. (HIMS): Here is what you need to know - MSN
HIMS Stock Eyes 2-Week Green Streak: Analyst Sees Nearly 20% Upside On Multi-Year Opportunity In Peptides - Stocktwits
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - Yahoo Finance
Hims & Hers Health, Inc. $HIMS Shares Sold by Capital World Investors - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Buys 43,826 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
HIMS News | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers H - The National Law Review
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today - TradingKey
Hims & Hers Health Stock (HIMS) Opinions on Biotech Sector Momentum - Quiver Quantitative
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Insider Monkey
HIMS vs. TEM: Which AI healthcare stock offers better upside now? - MSN
1,914,177 Shares in Hims & Hers Health, Inc. $HIMS Bought by Norges Bank - MarketBeat
Hims & Hers Health Options Spot-On: On June 1st, 185.47K Contracts Were Traded, With 1.08 Million Open Interest - Moomoo
Hims & Hers Health, Inc. Class A Trade Ideas — XETR:82W - TradingView
Hims & Hers Health Options Spot-On: On June 3rd, 96,548 Contracts Were Traded, With 1.06 Million Open Interest - Moomoo
How Investors Are Reacting To Hims & Hers Health (HIMS) Hiring a Longevity-Focused Chief Medical Officer - simplywall.st
HIMS Stock On The Mend? New Testosterone Push Builds As GLP-1 Gold Rush Gets Crowded - Stocktwits
Hims & Hers Health Options Spot-On: On June 5th, 153.61K Contracts Were Traded, With 1.08 Million Open Interest - Moomoo
Hims CMO Appointment Highlights Longevity Focus And Raises Valuation Questions - Yahoo Finance
Hims & Hers Stock Closes Eucalyptus Deal With a $20 Billion Peptide Bet on Deck. Here’s What to Expect - TIKR.com
Hims & Hers expands UK footprint with Eucalyptus acquisition - Pharmacy Business
What is behind Hims & Hers Health stock's recent drop in value today - Traders Union
Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock - The Globe and Mail
Hims & Hers Health stock price forecast: $34.06 resistance as HIMS climbs 1.82% - Traders Union
HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform - Stocktwits
HIMS Stock | Hims & Hers Health, Inc. Price, Quote, News & Analysis - TipRanks
Hims & Hers Health Jumps 7.0% Amid Sector-Wide Rally - AlphaStreet
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims - Hims & Hers Newsroom
Price-Driven Insight from (HIMS) for Rule-Based Strategy - Stock Traders Daily
Hims & Hers Names Anant Vinjamoori Chief Medical Officer of Hims Brand - INDIA New England News
Hims & Hers Stock Jumps: What's Happening Today? - Benzinga
4.37%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):